Skip to main content
. 2017 Jun 29;27:43. doi: 10.1038/s41533-017-0040-z

Fig. 4.

Fig. 4

Logistic regression model excluding concurrent asthma patients. SABA short-acting beta-agonists, SAMA short-acting muscarinic antagonists. † Comparisons were made against a reference category in the case of region (Wales), age (40–49 years), and year of diagnosis (2015)